ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.700
-0.040 (-2.30%)
At close: Sep 18, 2026, 4:00 PM EDT
1.690
-0.010 (-0.59%)
After-hours: Sep 18, 2026, 7:30 PM EDT
ALX Oncology Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
235.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 74.00M |
| Sutro Biopharma | 45.70M |
| Foghorn Therapeutics | 36.74M |
| Keros Therapeutics | 15.01M |
| Adagene | 9.29M |
| Whitehawk Therapeutics | 7.15M |
| Entrada Therapeutics | 4.69M |
| Camp4 Therapeutics | 4.22M |
ALXO News
- 5 days ago - ALX Oncology Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 9 days ago - ALX Oncology Holdings Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 10 days ago - ALX Oncology Holdings Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 18 days ago - ALX Oncology to Present at Upcoming Investor Conferences in September - GlobeNewsWire
- 6 weeks ago - ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - ALX Oncology Holdings Earnings release: Q2 2026 - Filings
- 6 weeks ago - ALX Oncology Holdings Quarterly report: Q2 2026 - Filings
- 2 months ago - ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - GlobeNewsWire